Effectiveness, Tolerability and Prescribing Choice of Antiviral Molecules Molnupiravir, Remdesivir and Nirmatrelvir/r: A Real-World Comparison in the First Ten Months of Use
Sign Up to like & getrecommendations! Published in 2023 at "Viruses"
DOI: 10.3390/v15041025
Abstract: In 2022, three antiviral drugs—molnupiravir, remdesivir and nirmatrelvir/ritonavir—were introduced for treatment of mild-to-moderate COVID-19 in high-risk patients. The aim of this study is the evaluation of their effectiveness and tolerability in a real-life setting. A… read more here.
Keywords: tolerability prescribing; tolerability; antiviral molecules; molnupiravir remdesivir ... See more keywords